These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2891723)

  • 1. Antigenic analysis of fimbrial proteins from Moraxella bovis.
    Moore LJ; Rutter JM
    J Clin Microbiol; 1987 Nov; 25(11):2063-70. PubMed ID: 2891723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation and quantitation of pilus antigens of Moraxella bovis by ELISA.
    Lepper AW; Hermans LR
    Aust Vet J; 1986 Dec; 63(12):401-5. PubMed ID: 2879528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A unified serotyping scheme for Moraxella bovis.
    Moore LJ; Lepper AW
    Vet Microbiol; 1991 Sep; 29(1):75-83. PubMed ID: 1683047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenicity and immunogenicity of piliated and nonpiliated phases of Moraxella bovis in calves.
    Jayappa HG; Lehr C
    Am J Vet Res; 1986 Oct; 47(10):2217-21. PubMed ID: 2877604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-bacterial cell enzyme-linked immunosorbent assay for cell-bound Moraxella bovis pili.
    Prieto CI; Rodriguez ME; Bosch A; Chirdo FG; Yantorno OM
    Vet Microbiol; 2003 Feb; 91(2-3):157-68. PubMed ID: 12458165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigenic characterization of Moraxella bovis, Moraxella bovoculi and Moraxella ovis strains with potential use in vaccines.
    Kowalski AP; Maboni G; Gressler LT; Espíndola JP; Balzan C; Tasca C; Guizzo JA; Conceição FR; Frandoloso R; de Vargas AC
    Vet Microbiol; 2017 Oct; 210():56-63. PubMed ID: 29103697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The protective efficacy of pili from different strains of Moraxella bovis within the same serogroup against infectious bovine keratoconjunctivitis.
    Lepper AW; Moore LJ; Atwell JL; Tennent JM
    Vet Microbiol; 1992 Sep; 32(2):177-87. PubMed ID: 1359693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serologic and protective characterization of Moraxella bovis pili.
    Lehr C; Jayappa HG; Goodnow RA
    Cornell Vet; 1985 Oct; 75(4):484-92. PubMed ID: 2865080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serologic cross-reactivity of Australian Moraxella bovis to vaccinal bacterin strains as determined by competitive ELISA.
    McConnel CS; Shum L; Gleeson BL; House JK
    Aust Vet J; 2008 Apr; 86(4):124-9. PubMed ID: 18363984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The protective efficacy of cloned Moraxella bovis pili in monovalent and multivalent vaccine formulations against experimentally induced infectious bovine keratoconjunctivitis (IBK).
    Lepper AW; Atwell JL; Lehrbach PR; Schwartzkoff CL; Egerton JR; Tennent JM
    Vet Microbiol; 1995 Jul; 45(2-3):129-38. PubMed ID: 7571364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Randomized controlled field trial to assess efficacy of a Moraxella bovis pilin-cytotoxin-Moraxella bovoculi cytotoxin subunit vaccine to prevent naturally occurring infectious bovine keratoconjunctivitis.
    Angelos JA; Gohary KG; Ball LM; Hess JF
    Am J Vet Res; 2012 Oct; 73(10):1670-5. PubMed ID: 23013196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against infectious bovine keratoconjunctivitis: protective efficacy and antibody response induced by pili of homologous and heterologous strains of Moraxella bovis.
    Lepper AW
    Aust Vet J; 1988 Oct; 65(10):310-6. PubMed ID: 2904257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectivity and virulence of Australian strains of Moraxella bovis for the murine and bovine eye in relation to pilus serogroup sub-unit size and degree of piliation.
    Lepper AW; Power BE
    Aust Vet J; 1988 Oct; 65(10):305-9. PubMed ID: 2904256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attachment of Moraxella bovis to calf corneal cells and inhibition by antiserum.
    Moore LJ; Rutter JM
    Aust Vet J; 1989 Feb; 66(2):39-42. PubMed ID: 2565715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of serum antibodies to Moraxella bovis in cattle in Nigeria.
    Makinde AA; Ezeh AO; Onoviran O; Umo I
    Br Vet J; 1985; 141(6):643-6. PubMed ID: 4063787
    [No Abstract]   [Full Text] [Related]  

  • 16. Outer membrane protein antigens of Moraxella bovis.
    Ostle AG; Rosenbusch RF
    Am J Vet Res; 1986 Jul; 47(7):1419-21. PubMed ID: 3740610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of shared magnetic antigenic determinants on whole Moraxella bovis pili by use of antisera to cyanogen bromide-cleaved M. bovis pilus protein.
    Greene WH; Grubbs ST; Potgieter LN
    Am J Vet Res; 2001 Aug; 62(8):1279-84. PubMed ID: 11497451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective antibody titres and antigenic competition in multivalent Dichelobacter nodosus fimbrial vaccines using characterised rDNA antigens.
    Raadsma HW; O'Meara TJ; Egerton JR; Lehrbach PR; Schwartzkoff CL
    Vet Immunol Immunopathol; 1994 Mar; 40(3):253-74. PubMed ID: 7909183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of the outer membrane protein antigens of British field isolates of Moraxella bovis.
    Horsnell JM; Teale CM
    Vet Microbiol; 1987 Nov; 15(3):181-9. PubMed ID: 3433652
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenic and immunogenic activity of flagella and fimbriae preparations from uropathogenic Proteus mirabilis.
    Legnani-Fajardo C; Zunino P; Algorta G; Laborde HF
    Can J Microbiol; 1991 Apr; 37(4):325-8. PubMed ID: 1680542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.